0.00Open0.00Pre Close0 Volume0 Open Interest45.00Strike Price0.00Turnover121.69%IV-30.89%PremiumMay 16, 2025Expiry Date10.62Intrinsic Value100Multiplier22DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7738Delta0.0297Gamma2.94Leverage Ratio-0.0670Theta-0.0187Rho-2.27Eff Leverage0.0253Vega
Scholar Rock Stock Discussion
Breakthrough: Scholar Rock's SMA Drug Shows 30.4% Patient Improvement in Phase 3 Trial
Scholar Rock's $437M War Chest: Can Their SMA Drug Deliver Returns for Investors?
Can This Phase 3 SMA Drug Transform Muscle Disease Treatment? Key Data Coming at MDA Conference
No comment yet